Skip to main content
. Author manuscript; available in PMC: 2023 Oct 22.
Published in final edited form as: J Neurosurg Pediatr. 2022 Apr 22;30(1):8–17. doi: 10.3171/2022.3.PEDS224

TABLE 1.

Patient characteristics

Initial ETV+CPC
(n = 521)
ETV revision following initial ETV+CPC
(n = 91)
Shunt placement following initial ETV+CPC
(n = 196)
P-value for comparison of initial ETV+CPC vs ETV revision
Corrected age at procedure (months) 2.1 [0.4, 5.8] 3.8 [2.1, 7.7] 3.5 [1.3, 6.4] <.0011
Male 304 (58.3%) 49 (53.8%) 128 (65.3%) 0.4242
Race 3 0.5532
 White 369 (77.5%) 66 (78.6%) 131 (73.6%)
 Black or African American 89 (18.7%) 17 (20.2%) 42 (23.6%)
 Other 18 (3.8%) 1 (1.2%) 5 (2.8%)
Etiology of hydrocephalus 0.4772
 Post-IVH secondary to prematurity 98 (18.8%) 20 (22.0%) 56 (28.6%)
 Myelomeningocele 158 (30.3%) 31 (34.1%) 36 (18.4%)
 Aqueductal stenosis 104 (20.0%) 19 (20.9%) 38 (19.4%)
 Other etiology 161 (30.9%) 21 (23.1%) 66 (33.7%)
  Post-Infectious 8 1 4
  Spontaneous ICH/IVH/SAH 28 5 14
  Posterior fossa tumor 4 0 1
  Supratentorial tumor 3 0 1
  Midbrain tumor/lesion 2 0 0
  Post-head injury 4 1 1
  Encephalocele 9 0 4
  Posterior fossa cyst 33 5 13
  Other intracranial cyst 6 0 3
  Communicating congenital hydrocephalus 34 3 15
  Other congenital 11 3 4
  Craniosynostosis 6 0 3
  Other 13 3 3
Frontal occipital horn ratio 4 0.59 (0.53, 0.67) 0.63 (0.58, 0.69) 0.66 [0.57, 0.72] <.0011
Bleeding during procedure 0.1112
 None 288 (55.3%) 61 (67.0%)
 Mild 206 (39.5%) 25 (27.5%)
 Moderate 16 (3.1%) 4 (4.4%)
 Severe 11 (2.1%) 1 (1.1%)
Dilation method 5 0.0352
 Forceps 7 (1.3%) 2 (2.4%)
 Fogarty 64 (12.3%) 4 (4.7%)
 Neuroballoon 93 (17.9%) 26 (30.6%)
 Spreader 1 (0.2%) 0 (0.0%)
 Endoscope 301 (57.9%) 44 (51.8%)
 Multiple 54 (10.4%) 9 (10.6%)
1

Wilcoxon rank-sum test with unpooled variance estimated comparing initial ETV+CPC and ETV revision following initial ETV+CPC.

2

Fisher’s exact test comparing inital ETV+CPC and ETV revision following initial ETV+CPC.

3

Missing on 45 patients.

4

Missing on 3 patient at initial ETV+CPC and 9 patients at shunt placement following initial ETV+CPC.

5

Missing on 6 patients at ETV revision following initial ETV+CPC.